<unk>  is a benzodiazepine derivative that has anxiolytic, sedative, and anticonvulsant properties. It is not widely used; as of August 2018 it was marketed in Belgium, Luxembourg, Portugal, Brazil, and Japan. In 2019, it has been retired from the Belgian market.
Cloxazolam
Triazolam
Haloxazolam
Remimazolam
Flutazolam
Adinazolam
Ketazolam
Mexazolam